fda drug shortages semaglutide injection shortage resolved 2025 FDA: Ozempic and Wegovy is over FDA ends semaglutide shortage, closing

A clear semaglutide solution should not turn pink over time

At the time the MDL was formed, at least 30 Ozempic vision-loss claims were consolidated into the federal group lawsuit

Patients using semaglutide are typically asked to reduce their intake by about 500 calories a day and get at least 150 minutes of exercise per week

Concerns about GLP-1 receptor agonists and thyroid function arose primarily from preclinical animal studies, particularly in rodents, where semaglutide and similar medications were associated with thyroid C-cell tumours, including medullary thyroid carcinoma

The medication is typically started at a low dose, which is gradually increased every four weeks or so